ArticleResearch and practice in thrombosis and haemostasis2026
Association of the sarcopenia index based on the serum creatinine to cystatin C ratio and genetic risk with venous thromboembolism: a population-based cohort study.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Venous thromboembolism (VTE) results from the interplay between environmental and genetic factors. The relationship between sarcopenia index (SI) and VTE risk remains unclear. The combined effects of SI and genetic susceptibility on VTE risk have not been fully elucidated. We therefore investigated these associations using data from the UK Biobank. Methods: Cox proportional hazards models were used to assess the relationship between SI and genetic susceptibility with incident VTE. Restricted cubic spline models were applied to examine the exposure-response relationships. Results: Among 447,681 participants, 12,008 developed VTE during a median follow-up of 13.4 years. Higher SI was associated with a lower risk of VTE. The fully adjusted hazard ratios (HRs) for Q2 to Q4 vs Q1 were 0.88 (95% CI, 0.83-0.92), 0.82 (95% CI, 0.78-0.87), and 0.77 (95% CI, 0.72-0.82), respectively. Restricted cubic spline analysis showed an inverse nonlinear association between SI and VTE ( Conclusion: Participants with lower SI had a significantly higher risk of VTE. Consistent with previous UK Biobank findings, higher polygenic risk score levels were associated with an increased risk of VTE. Moreover, participants with both low SI levels and high genetic risk exhibited the greatest risk of VTE. These findings suggest that SI may serve as a simple and accessible marker for identifying individuals at elevated risk of VTE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.